EUROGIN 2024 - International Multidisciplinary HPV Congress

EUROGIN 2024 - International Multidisciplinary HPV Congress is organized by European Research Organisation on Genital Infection and Neoplasia (EUROGIN) and will be held from Mar 13 - 16, 2024 at Stockholm Waterfront Congress Centre, Stockholm, Sweden.

Description:
EUROGIN is the world's leading international congress on HPV infections and associated cancers with a focus on prevention and diagnostics.

The event aims at translating scientific and evidence-based research into clinical practice through its high-quality and innovative program drawn up by outstanding international leaders. The conference offers a forum to exchange knowledge and experience with peers from all over the world.

What is EUROGIN:
The Leading International Multidisciplinary HPV Congress

Started in 1993 as a conference where scientific progress and clinical practice converge, EUROGIN shares translational research with an international scientific community aiming at accelerating the reduction of the burden of HPV-related cancers and their mortality.

In cooperation with a highly recognized research groups, the EUROGIN 2024 conference draws up an inventory of recent scientific research to provide healthcare workers and decision-makers with a comprehensive strategy to fight diseases related to human papillomavirus.

The conference focuses on translating scientific and evidence-based research into clinical practice.

EUROGIN Program Highlights:

• High-level Scientific Program
• A full overview of current scientific developments in the field of cervical cancer and other HPV related diseases.
• EUROGIN focuses on translating scientific and evidence-based research into clinical practice by offering a high quality and innovative scientific program drawn up by outstanding international leaders from the academic sector as well as  professional and patient organizations.
• The program aims to foster future advancements by providing fundamental insights to physicians and young researchers.

Additional details will be posted as soon as information is available.